Do low HDL-C and reduced large HDL particles reflect impaired cholesterol efflux capacity and higher atherosclerotic risk?

The relationship between high-density lipoprotein (HDL) metrics and cardiovascular health has evolved beyond simple cholesterol concentration to include the functional quality and size of HDL particles. Current research strongly supports the claim that low HDL cholesterol (HDL-C) and a reduction in large HDL particles are indicators of impaired cholesterol efflux capacity (CEC) and elevated atherosclerotic cardiovascular disease (ASCVD) risk.

Clinical and effectiveness evidence

Extensive longitudinal data demonstrate that both low HDL-C and a deficit in large HDL particles serve as independent markers for increased ASCVD risk.

• Large HDL and CHD Risk: In the Women's Health Study, individuals in the highest quartile of "very large" HDL particles had a 51% lower risk of incident coronary heart disease (CHD) compared to those in the lowest quartile.
• Atherosclerotic Markers: Research consistently shows an inverse relationship between HDL particle size and subclinical atherosclerosis, even in populations with varied metabolic health, such as those with severe obesity or type 1 diabetes.
• Predictive Value of Efflux: While HDL-C measures the volume of cholesterol carried, cholesterol efflux capacity (CEC) measures the rate of removal. Studies indicate that CEC is a more robust predictor of cardiovascular events than HDL-C concentration alone.

Mechanistic explanations

The association between particle size and cardiovascular risk is driven by the specific biochemical functions of mature HDL subfractions.

• Cholesterol Efflux Capacity (CEC): Large HDL particles (typically >9.6 nm) are critical drivers of total serum CEC. They are enriched with fatty-acylated Apolipoprotein A-I (ApoA-I) proteoforms and ApoA-II, which stabilize the particle structure.
• Transporter Interactions: These larger particles facilitate superior interactions with key cholesterol transporters, specifically ABCA1 and SR-BI, which are responsible for removing cholesterol from macrophages in the arterial wall.
• Reverse Cholesterol Transport: A deficiency in large HDL particles indicates a breakdown in the reverse cholesterol transport pathway, leading to the accumulation of cholesterol within the vessel walls and the subsequent progression of atherosclerotic plaques.

Bottom line

Low HDL-C and a reduced concentration of large HDL particles are scientifically validated markers of lower cholesterol efflux capacity and increased atherosclerotic risk. For a 37-year-old female, while these metrics provide deep mechanistic insight into vascular health, they are currently used more as research-grade indicators of risk rather than standardized targets in routine clinical guidelines.